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A novel GNAS mutation in an infant 
boy with pseudohypoparathyroidism 
type Ia and normal serum 
calcium and phosphate levels
Mutação nova no GNAS em um menino com 
pseudo-hipoparatireoidismo tipo Ia e dosagens 
séricas normais de cálcio e fósforo
Mariana Tenorio Antunes Reis1,2, Andreina Cattani3,  
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SUMMARY
The objective of this study was to describe a new mutation in GNAS in a family with pseudo-
hypoparathyroidism type Ia (PHP Ia), a rare osteometabolic disease. An 8-month-old boy was 
seen by an Endocrinologist due to obesity and low growth velocity. Noteworthy, his mother 
exhibited typical Albright hereditary osteodystrophy (AHO) phenotype. The clinical diagnosis of 
PHP Ia was suspected. The GNAS coding region from mother and son was amplified and direc-
tly sequenced. A novel heterozygous missense mutation (c.673T>C) was identified in exon 5 in 
both patients. In this family, the mother’s clinical picture was the clue for the son’s diagnosis. 
Molecular analysis of GNAS confirmed the diagnosis of PHP Ia in both patients and the child’s 
early diagnosis was possible. Moreover, this novel missense substitution expands the spectrum 
of GNAS mutations associated with this disorder and allows for genetic counseling of this family. 
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SUMÁRIO
O objetivo deste estudo foi descrever uma nova mutação no GNAS em uma família com pseudo-
-hipoparatireoidismo tipo Ia (PHP Ia), doença osteometabólica rara. Um garoto de oito meses 
foi visto por um endocrinologista por obesidade e baixa velocidade de crescimento. Chamava 
a atenção o fato de sua mãe apresentar fenótipo típico da osteodistrofia hereditária de Albright 
(OHA). O diagnóstico clínico de PHP Ia foi suspeitado. A região codificadora do GNAS da mãe 
e do filho foi amplificada e submetida ao sequenciamento direto. Uma nova mutação missense 
em heterozigose (c.673T>C) foi identificada no éxon 5 em ambos. O quadro clínico materno foi 
a pista para o diagnóstico do filho. A análise molecular do GNAS confirmou o diagnóstico de 
PHP Ia nos dois pacientes possibilitando o diagnóstico precoce da criança. Além disso, essa 
nova substituição missense expande o espectro de mutações no GNAS associadas a essa doen-
ça e permite o aconselhamento genético nesta família. Arq Bras Endocrinol Metab. 2010;54(8):728-31
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INTRODUCTION
In 1942, Fuller Albright and cols. described the first human disease attributed to hormonal resistance, 
which was named pseudohypoparathyroidism (PHP). 
This condition has the same biochemical features as hy-
poparathyroidism, except for the elevation of PTH (1).
PHP is a rare, sporadic or familial disorder that is 
classified into two types according to the renal response 
to exogenous PTH administration: PHP type I (PHP 
I), when urinary cyclic adenosine monophosphate 
(cAMP) excretion and phosphaturic response are re-
duced (compared to normal subjects), and PHP type 
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II (PHP II), when urinary cAMP excretion is normal 
but the phosphaturic response is absent. Lastly, PHP 
I is divided into subtypes Ia, Ib and Ic based on dif-
ferent phenotypes, genetic findings and pathogenesis. 
The cause of these subtypes is mutations or imprinting 
abnormalities in the stimulatory alpha-subunit G pro-
tein (Gsα) whose signaling is essential for the actions of 
PTH and of many other hormones (2).
PHP Ia is characterized by resistance to PTH and 
to several additional hormones that bind to G protein-
coupled receptors (GPCRs). Affected patients display 
variable developmental and somatic features known as 
Albright hereditary osteodystrophy (AHO), which com-
prises obesity, short stature, brachydactyly, round face, 
ectopic ossification and/or mental retardation. Most of 
the PHP Ia patients have a loss-of-function of Gsα due 
to a maternal heterozygous mutation in exons 1-13 of 
GNAS, the gene responsible for encoding Gsα (3).
The same mutations found in GNAS leading to 
PHP Ia are found in patients with pseudopseudohy-
poparathyroidism (PPHP), who display AHO features 
without hormonal resistance, so one family can pres-
ent cases of PHP Ia and PPHP. The determination of 
which one is going to be found depends on parental 
origin, meaning that subjects that inherited GNAS mu-
tations from the mother exhibit PHP Ia whereas those 
who inherited the same mutations from the father ex-
hibit PPHP. This inheritance pattern is consistent with 
paternal imprint of Gsα (4).
In this paper, we present a family in which the mother 
has AHO features and hypocalcemia symptoms while her 
son has obesity and low growth velocity. Based on the 
mother’s clinical picture, diagnosis of PHP Ia was sus-
pected and confirmed after complementary tests and the 
suspicion that her son had the same disease (PHP Ia) was 
raised. To validate this, the aim of this study was to search 
for mutations in GNAS in both individuals to establish 
the molecular etiology of PHP Ia and its heritability.
SUBJECT AND METHODS
Case report
The proband was a term newborn, weighting 3,400 g 
and measuring 47 cm, without history of perinatal com-
plications. At 8 months, he was admitted to the Endo-
crinology Unit of Universidad Catolica in Chile due to 
obesity and low growth velocity. His physical examina-
tion showed a weight of 11.44 kg (SD = + 2.19), stature 
of 68.2 cm (SD = - 0.78), body mass index (BMI) of 
24.6 kg/m2 (weight-for-length percentile > P97), with-
out any other alterations. At that time, hypothyroidism 
was diagnosed and treated with levothyroxine.
Noteworthy, his mother (Figure 1) exhibited typi-
cal AHO phenotype such as short stature, round face, 
short neck and brachydactyly. In addition, she had par-
esthesia, hypothyroidism and basal nucleus calcification 
on cranial CT scan. These data and her laboratorial 
profile (Table 1) were compatible with PHP Ia.
Although the patient had normal serum concentra-
tions of calcium and phosphate for his age, the diag-
nosis of PHP Ia was suspected because of his elevated 
levels of PTH and his mother’s background (Tables 1 
and 2). To confirm this possibility, the GNAS coding 
region of both patients was studied.
Molecular analysis
The study protocol was approved by the ethics commit-
tee, and the informed consent was obtained from the 
parents. After obtaining written informed consent for 
the study, peripheral blood leukocytes genomic DNA 
was extracted from the patient and his mother. Ten in-
tronic primer pairs were used to amplify exons 1-13 
from the GNAS gene. After amplification confirmation 
by electrophoresis in agarosis gel, PCR products were 
submitted to automatic sequencing reaction. The re-
sults were compared to the wild type GNAS sequence 
published at www.ensembl.org (ENST00000371085).
Figure 1. Patient at 3.3 years of age, his mother and his unaffected 
grandmother.
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cal features of AHO, symptoms of hypocalcemia and 
resistance to TSH, which were the clues for the son’s 
diagnosis.
Although hypocalcemia is one of the most promi-
nent features in PHP Ia, some patients have been re-
ported to have normocalcemia. To explain this finding, 
Tamada and cols. (5) consider at least two hypothesis: a 
dietary intake rich in calcium and increased serum con-
centrations of active vitamin D, or bone responsiveness 
to PTH may compensate for hypocalcemia. In the lat-
ter, bone demineralization has been reported to occur 
frequently in PHP Ia and Ib, however, clinically signifi-
cant hyperparathyroid bone disease with radiologic or 
histologic features of osteitis fibrosa cystica is uncom-
mon (5).
In this case, the patient was only one and a half years 
old when PTH levels were measured for the first time. 
So, we believe that the patient was still normocalcemic 
as PHP Ia diagnosis was precocious. The raised PTH 
concentrations suggest PTH resistance and he would 
probably have developed hypocalcemia and its symp-
toms if calcium and vitamin D supplementation were 
not introduced.
Because Gsα inheritance pattern is consistent with 
the parental origin-specificity, it is known that PHP Ia 
results from a heterozygous inactivating mutation at 
GNAS inherited from the maternal allele while PPHP 
results from a mutation in the paternal allele (6). Thus, 
in the family studied, Gsα proband’s mutation was ma-
ternally inherited and this is consistent with PHP Ia. 
Not surprisingly, normocalcemia combined with the 
AHO phenotype could be misdiagnosed as PPHP.
A different substitution in the same codon (p.I106S) 
within Gsα coding region was previously described as 
the cause of PHP Ia in an infant boy. The clinical find-
ings of congenital hypothyroidism, calcinosis cutis and 
AHO phenotype during infancy were the reasons to 
consider that diagnosis. As for the boy described here, 
this patient had normocalcemia and elevated PTH lev-
els at 7 months, however, our patient does not have 
skin lesions. The authors think that p.I106S substitu-
tion results in a defective Gsα because the residue Ile-
106 is located within the helical domain of the pro-
tein, which is considered a regulator and activator of its 
function. Moreover, the part within the helical domain 
that extends from residue 70 to 140 is functionally im-
portant for adenylyl cyclase activation. In addition, sub-
stitution of the hydrophobic aa isoleucine by the polar 
aa serine probably leads to Gsα impaired function, as a 
Normal
height
27 yrs
H: 139 cm
3.3 yrs
H: 93 cmA B C
Table 1. Mother’s laboratorial profile
Analyte Adult normal range Result
Ca 8.8 – 10.2 mg/dL 7.6
P 2.3 – 4.6 mg/dL 4.6
PTH 11 – 62 pg/mL 691
Table 2. Patient’s laboratorial profile
Analyte Childnormal range
Chronological age
9 m 1 ½ yrs 2 ½ yrs 5 ¾ yrs
TSH 0.8 – 6.3 uU/mL 16.6 4.9 1.7 0.1
T4 7.3 – 15.3 ug/dL 8.1 11.0 11.1 11.7
T3 105 – 296 ng/dL 202
FT4 0.7 – 1.5 ng/dL 1.1
Ca 8.8 – 10.8 mg/dL 9.8 9.7 8.9 9.2
P 5.0 – 10.8 mg/dL 6.6 6.3 5.5 5.5
PTH 11 – 62 pg/mL 132 87 144
RESULTS
A novel heterozygous missense mutation was identified 
in exon 5 of GNAS in the proband: a substitution of T 
→ C at nucleotide 673 (c.673T>C), leading to an ami-
no acid (aa) replacement in codon 106 of isoIeucine → 
threonine (p.l106T). His mother had the same mutation 
confirming the proband’s mutation origin (Figure 2).
Figure 2. (A) Pedigree of the family. Electropherograms of part of GNAS 
exon 5 from a normal control (B) and the child sample (C); the arrow shows 
the substitution T → C, in heterozygous, that was also detected in the 
mother’s child; the small boxes highlight the codon 106.
DISCUSSION
In this report, we present a patient with initial com-
plaints of obesity and low growth velocity, in whom 
the initial laboratorial alterations were hypothyroidism 
without evidence of thyroid autoimmunity (negative 
thyroid autoantibodies). The patient had normal cal-
cium and phosphate levels, which did not lead to sus-
picion of PHP at first. However, his mother had typi-
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Table 3. Multiple sequence alignment of GNAS in different species
Animals Species Protein Acc. Gene Protein sequence
Human Homo sapiens NP_536350.2 GNAS NNLKEAIETIVAAMSNLVP
Chimpanzee P. troglodytes XP_525370.2 GNAS NNLKEAIETIVAAMSNLVP
Dog Canis lupus familiaris NP_001003263.1 GNAS NNLKEAIETIVAAMSNLVP
Cattle Bos taurus NP_851364.1 GNAS NNLKEAIETIVAAMSNLVP
Red jungle fowl Gallus gallus XP_001231580.1 GNAS NNIKEAIETIVTAMGNLAP
Zebrafish Danio rerio XP_685500.2 LOC557353 NNIKEAIETIVTAMSVLVP
Fruit fly D. melanogaster NP_477506.1 G-salpha60A KNIRDAILTITGAMSTLNP
Mosquito A. gambiae XP_320433.1 AgaP_AGAP012095 KNIRDAILTITGAMSTLTP
Roundworm C. elegans NP_490817.3 gsa-1 RNVRDAMQVILRAMDEIVP
The residue Ile-106 (I) is shown in bold at “protein sequence” column.
result of conformational changes within its helical do-
main, affecting adenylyl cyclase activation for example. 
Furthermore, the “variant” allele type (p.I106S) was 
not found in over 100 analyzed alleles from healthy 
controls of German descent suggesting that it is not a 
polymorphism (7).
For the same reasons, we speculate that the substi-
tution p.I106T is also the causative mutation of our 
patient even without performing a functional study. In 
both cases, serine and threonine are polar aa in opposi-
tion to isoleucine which is a hydrophobic aa. Further-
more, the correspondent human residue Ile-106 of Gsα 
is highly conserved in different species such as the chim-
panzee, dog, cow, chicken, zebrafish, fruit fly, mosquito 
and roundworm (C. elegans), indicating that a replace-
ment of this aa may be deleterious. Table 3 shows the 
alignment generated by the MUSCLE software (8).
The presence of AHO features and normocalcemia 
does not always mean PPHP, especially if the mutation 
is maternally inherited. In the latter case, the correct 
diagnosis is PHP Ia and follow-up calcium and PTH 
levels should be recommended in order to start early 
treatment.
In our study case, the mother’s clinical picture al-
lowed the child’s precocious diagnosis of PHP Ia and 
genetic counseling for this family. In both patients, 
PHP Ia was due to a novel missense mutation in the 
GNAS gene (p.I106S) in the heterozygous state.
Although PHP is a rare disorder, in many cases, 
clinical manifestations are insidious and even if hypocal-
cemia symptoms are evident, sometimes the condition 
can be misdiagnosed as epilepsy. Therefore, its preco-
cious diagnosis and treatment are important to mini-
mize the development of complications such as basal 
nuclei calcification, cataract, as well as the consequen-
ces of wrong treatment.
Disclosure: no potential conflict of interest relevant to this article 
was reported.
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